182 related articles for article (PubMed ID: 37987347)
1. A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology.
LoCastro E; Paudyal R; Konar AS; LaViolette PS; Akin O; Hatzoglou V; Goh AC; Bochner BH; Rosenberg J; Wong RJ; Lee NY; Schwartz LH; Shukla-Dave A
Tomography; 2023 Nov; 9(6):2052-2066. PubMed ID: 37987347
[TBL] [Abstract][Full Text] [Related]
2. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
[TBL] [Abstract][Full Text] [Related]
3. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.
Shukla-Dave A; Obuchowski NA; Chenevert TL; Jambawalikar S; Schwartz LH; Malyarenko D; Huang W; Noworolski SM; Young RJ; Shiroishi MS; Kim H; Coolens C; Laue H; Chung C; Rosen M; Boss M; Jackson EF
J Magn Reson Imaging; 2019 Jun; 49(7):e101-e121. PubMed ID: 30451345
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
[TBL] [Abstract][Full Text] [Related]
5. Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.
Reynolds HM; Tadimalla S; Wang YF; Montazerolghaem M; Sun Y; Williams S; Mitchell C; Finnegan ME; Murphy DG; Haworth A
Cancer Imaging; 2022 Dec; 22(1):71. PubMed ID: 36536464
[TBL] [Abstract][Full Text] [Related]
6. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard.
Gibbons M; Simko JP; Carroll PR; Noworolski SM
Magn Reson Imaging; 2023 Jun; 99():48-57. PubMed ID: 36641104
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
11. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
[TBL] [Abstract][Full Text] [Related]
12. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric Magnetic Resonance Imaging of the Prostate for Tumour Detection and Local Staging: Imaging in 1.5T and Histopathologic Correlation.
Loggitsi D; Gyftopoulos A; Economopoulos N; Apostolaki A; Kalogeropoulos T; Thanos A; Alexopoulou E; Kelekis NL
Can Assoc Radiol J; 2017 Nov; 68(4):379-386. PubMed ID: 28720413
[TBL] [Abstract][Full Text] [Related]
14. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
15. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
[TBL] [Abstract][Full Text] [Related]
16. Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study.
Bosaily AE; Frangou E; Ahmed HU; Emberton M; Punwani S; Kaplan R; Brown LC; Freeman A; Jameson C; Hindley R; Peppercorn D; Thrower A; Winkler M; Barwick T; Stewart V; Burns-Cox N; Burn P; Ghei M; Kumaradevan J; Prasad R; Ash-Miles J; Shergill I; Agarwal S; Rosario D; Salim F; Bott S; Evans H; Henderson A; Ghosh S; Dudderidge T; Smart J; Tung K; Kirkham A;
Eur Urol; 2020 Oct; 78(4):503-511. PubMed ID: 32312543
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
19. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection.
Gholizadeh N; Greer PB; Simpson J; Goodwin J; Fu C; Lau P; Siddique S; Heerschap A; Ramadan S
J Biomed Sci; 2021 Jul; 28(1):54. PubMed ID: 34281540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
